MannKind Corp
MNKD
#5922
Rank
โ‚น120.31 B
Marketcap
โ‚น374.18
Share price
-4.38%
Change (1 day)
24.80%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2026 (TTM): -โ‚น6.50

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is -โ‚น6.66. In 2025 the company made an earnings per share (EPS) of โ‚น1.90 a decrease over its 2024 EPS that were of โ‚น9.52.

EPS history for MannKind Corp from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น6.50-441.22%
2025โ‚น1.90-80%
2024โ‚น9.52
2022-โ‚น32.376.25%
2021-โ‚น30.4728%
2020-โ‚น23.80-7.41%
2019-โ‚น25.71
2017-โ‚น105.68-188.1%
2016โ‚น119.96-128.31%
2015-โ‚น423.6974.51%
2014-โ‚น242.79-20.31%
2013-โ‚น304.67-32.63%
2012-โ‚น452.25-28.03%
2011-โ‚น628.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น124.73-1,971.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
โ‚น408.97-6,236.29%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
โ‚น2,687-40,421.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น340.37-5,206.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
โ‚น278.01-4,271.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-โ‚น801.67 11,928.57%๐Ÿ‡บ๐Ÿ‡ธ USA